Newsletter Archive

  1. 08.15.18 -- How To Tell If A CRA Candidate Is Lying
    8/15/2018
    08/15/18 Clinical Leader Newsletter
  2. 08.13.18 -- Lilly Reduces White Space For Quicker Regulatory Approvals
    8/13/2018
    08/13/18 Clinical Leader Newsletter
  3. 08.08.18 -- 10 Key Ingredients For Small Pharma GCP Quality Systems
    8/8/2018
    08/08/18 Clinical Leader Newsletter
  4. 08.06.18 -- Clinical Trials: Not Broken, But In Need Of Repair
    8/6/2018
    08/06/18 Clinical Leader Newsletter
  5. 08.01.18 -- Phase 1 Trial Targets The Immune System, Not The Cancer
    8/1/2018
    08/01/18 Clinical Leader Newsletter
  6. 07.30.18 -- Lessons In Patient-Centricity From Rare Disease Clinical Trials
    7/30/2018
    07/30/18 Clinical Leader Newsletter
  7. 07.25.18 -- 4 Keys To Making Stakeholder Partnerships Work
    7/25/2018
    07/25/18 Clinical Leader Newsletter
  8. 07.23.18 -- A Cost-Utility Analysis Of Vertex’s CF Drugs — What It Teaches Us About Trial Design
    7/23/2018
    07/23/18 Clinical Leader Newsletter
  9. 07.18.18 -- Will Profit Motive Be The First Big Test For RTT Legislation?
    7/18/2018
    07/18/18 Clinical Leader Newsletter
  10. 07.16.18 -- QbD In Clinical Trials: A Focused Approach To Quality Assurance And Risk Management
    7/16/2018
    07/16/18 Clinical Leader Newsletter